Neurocrine Biosciences, Inc. (NBIX)
146.23
-5.60
(-3.69%)
USD |
NASDAQ |
Sep 18, 16:00
146.54
+0.31
(+0.21%)
After-Hours: 20:00
Neurocrine Biosciences 30-Day Average Daily Volume : 1.156M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.156M |
| September 17, 2026 | 1.108M |
| September 16, 2026 | 1.112M |
| September 15, 2026 | 1.118M |
| September 14, 2026 | 1.124M |
| September 11, 2026 | 1.250M |
| September 10, 2026 | 1.293M |
| September 09, 2026 | 1.299M |
| September 08, 2026 | 1.308M |
| September 04, 2026 | 1.316M |
| September 03, 2026 | 1.323M |
| September 02, 2026 | 1.334M |
| September 01, 2026 | 1.339M |
| August 31, 2026 | 1.353M |
| August 28, 2026 | 1.328M |
| August 27, 2026 | 1.332M |
| August 26, 2026 | 1.338M |
| August 25, 2026 | 1.330M |
| August 24, 2026 | 1.330M |
| August 21, 2026 | 1.342M |
| August 20, 2026 | 1.336M |
| August 19, 2026 | 1.346M |
| August 18, 2026 | 1.346M |
| August 17, 2026 | 1.346M |
| August 14, 2026 | 1.338M |
| Date | Value |
|---|---|
| August 13, 2026 | 1.336M |
| August 12, 2026 | 1.298M |
| August 11, 2026 | 1.264M |
| August 10, 2026 | 1.283M |
| August 07, 2026 | 1.316M |
| August 06, 2026 | 1.310M |
| August 05, 2026 | 1.310M |
| August 04, 2026 | 1.303M |
| August 03, 2026 | 1.297M |
| July 31, 2026 | 1.337M |
| July 30, 2026 | 1.218M |
| July 29, 2026 | 1.177M |
| July 28, 2026 | 1.183M |
| July 27, 2026 | 1.174M |
| July 24, 2026 | 1.164M |
| July 23, 2026 | 1.163M |
| July 22, 2026 | 1.163M |
| July 21, 2026 | 1.150M |
| July 20, 2026 | 1.142M |
| July 17, 2026 | 1.152M |
| July 16, 2026 | 1.186M |
| July 15, 2026 | 1.191M |
| July 14, 2026 | 1.202M |
| July 13, 2026 | 1.231M |
| July 10, 2026 | 1.214M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Amarin Corp. Plc | 71190.27 |
| Liquidia Corp. | 1.508M |
| BioCryst Pharmaceuticals, Inc. | 4.142M |
| Halozyme Therapeutics, Inc. | 2.301M |
| Iovance Biotherapeutics, Inc. | 15.89M |